GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Yibai Pharmaceutical Co Ltd (SHSE:600594) » Definitions » Market Cap

Guizhou Yibai Pharmaceutical Co (SHSE:600594) Market Cap : ¥2,637 Mil (As of Apr. 10, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Guizhou Yibai Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Guizhou Yibai Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥3.81. Guizhou Yibai Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 792 Mil. Therefore, Guizhou Yibai Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥3,017 Mil.

Guizhou Yibai Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥3,762 Mil) to Jun. 2024 (¥2,376 Mil) but then increased from Jun. 2024 (¥2,376 Mil) to Sep. 2024 (¥3,017 Mil).

Guizhou Yibai Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥6,438 Mil) to Dec. 2022 (¥4,379 Mil) but then increased from Dec. 2022 (¥4,379 Mil) to Dec. 2023 (¥4,506 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guizhou Yibai Pharmaceutical Co's Enterprise Value for Today is ¥2,931 Mil.


Guizhou Yibai Pharmaceutical Co Market Cap Historical Data

The historical data trend for Guizhou Yibai Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Yibai Pharmaceutical Co Market Cap Chart

Guizhou Yibai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,943.80 4,133.86 6,438.37 4,379.36 4,506.06

Guizhou Yibai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,593.18 4,506.06 3,761.65 2,375.78 3,017.24

Competitive Comparison of Guizhou Yibai Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Yibai Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhou Yibai Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Yibai Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Guizhou Yibai Pharmaceutical Co's Market Cap falls into.


;
;

Guizhou Yibai Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Guizhou Yibai Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥5.69*791.927
=¥4,506

Guizhou Yibai Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥3.81*791.927
=¥3,017

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhou Yibai Pharmaceutical Co  (SHSE:600594) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Guizhou Yibai Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Guizhou Yibai Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Yibai Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
Executives
Dou Qi Ling Director
Gan Ning Director
Lang Hong Ping Director
Xia Xiao Hui senior management
Dou Ya Qi Director
Wang Zhi Wei Director
Zhu Yue Xing Director
Dai Yuan Fu senior management
Zhang Sheng Gui senior management
Feng Zhi Gang senior management
Yue Wei Director
Liu Hua Supervisors
Ye Xiang Wu Director
Jian Wei Guang Director

Guizhou Yibai Pharmaceutical Co Headlines

No Headlines